High methylation levels of PCDH10 predict poor prognosis in patients with pancreatic ductal adenocarcinoma

Abstract Background Pancreatic ductal adenocarcinoma (PDAC) is one of the most lethal malignancies and is not a clinically homogeneous disease, but subsets of patients with distinct prognosis and response to therapy can be identified by genome-wide analyses. Mutations in major PDAC driver genes were...

Cijeli opis

Bibliografski detalji

Glavni autori:	Maria Cristina Curia, Fabiana Fantini, Rossano Lattanzio, Francesca Tavano, Francesco Di Mola, Mauro Piantelli, Pasquale Battista, Pierluigi Di Sebastiano, Alessandro Cama
Format:	Artigo
Jezik:	Inglês
Izdano:	BMC 2019-05-01
Serija:	BMC Cancer
Teme:	Pancreatic ductal adenocarcinoma Epigenetics Protocadherins PCDH10 DNA methylation Survival
Online pristup:	http://link.springer.com/article/10.1186/s12885-019-5616-2
Oznake:	Dodaj oznaku Bez oznaka, Budi prvi tko označuje ovaj zapis!